Chimera Investment (NYSE:CIM) PT Raised to $16.00 at Keefe, Bruyette & Woods

Chimera Investment (NYSE:CIM) had its target price increased by Keefe, Bruyette & Woods from $15.00 to $16.00 in a research report issued on Thursday, Benzinga reports. The brokerage currently has a “market perform” rating on the real estate investment trust’s stock. Keefe, Bruyette & Woods’ target price points to a potential upside of 10.12% from the company’s current price.

Separately, StockNews.com raised shares of Chimera Investment from a “hold” rating to a “buy” rating in a report on Wednesday.

Chimera Investment Trading Down 0.5 %

Chimera Investment stock traded down $0.08 during trading on Thursday, reaching $14.53. The company had a trading volume of 538,002 shares, compared to its average volume of 651,685. Chimera Investment has a 12-month low of $11.28 and a 12-month high of $18.78. The stock’s 50 day moving average price is $13.59 and its two-hundred day moving average price is $13.51. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio of 9.50 and a beta of 1.72. The company has a debt-to-equity ratio of 3.70, a quick ratio of 5.46 and a current ratio of 5.46.

Chimera Investment (NYSE:CIM) last released its quarterly earnings data on Wednesday, August 7th. The real estate investment trust reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.03. Chimera Investment had a net margin of 25.73% and a return on equity of 7.46%. The company had revenue of $186.72 million during the quarter, compared to the consensus estimate of $66.50 million. During the same period in the previous year, the firm earned $0.36 earnings per share. As a group, equities analysts expect that Chimera Investment will post 1.41 earnings per share for the current fiscal year.

Insider Transactions at Chimera Investment

In other Chimera Investment news, Director Gerard Creagh purchased 10,000 shares of Chimera Investment stock in a transaction dated Monday, June 17th. The shares were bought at an average cost of $13.07 per share, for a total transaction of $130,700.00. Following the transaction, the director now owns 125,899 shares in the company, valued at approximately $1,645,499.93. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.91% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Arkadios Wealth Advisors increased its holdings in shares of Chimera Investment by 121.7% in the 2nd quarter. Arkadios Wealth Advisors now owns 30,028 shares of the real estate investment trust’s stock worth $384,000 after acquiring an additional 16,482 shares during the period. Harbour Investments Inc. acquired a new stake in shares of Chimera Investment in the 2nd quarter worth about $796,000. AlphaCentric Advisors LLC acquired a new stake in shares of Chimera Investment in the 2nd quarter worth about $179,000. Cetera Advisors LLC acquired a new stake in shares of Chimera Investment in the 1st quarter worth about $63,000. Finally, Bayesian Capital Management LP acquired a new position in Chimera Investment during the 1st quarter valued at about $116,000. 48.44% of the stock is currently owned by institutional investors.

About Chimera Investment

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.